|
| Categories: Additional article for Therapies |
| Additional article for Therapies | |
|
|
Saurian saliva – the solution of the mystery diabetes?
|
| |
At the end of the year 2003, there was an article in the press which said that in the saliva of the american saurian “ Gila Monstre” was found a substance that gives hope for a better diabetes type 2 treatment. The substance has been called “Exendin-4”. It was supposed not only to reduce the blood sugar and to slow down the emptying of the stomach, but also to increase the number of the insulin-producing beta-cells.
3 years later, the following article appeared in the “American Journal of Health-System Pharmacy, Vol. 63 (2006), Issue 5, 411-418” which is summarized as follows:
Exenatides, substances that are similiar to the insulin of the american saurian Gila Monstre, showed that they increase the insulin secretion, as well as that they can sometimes avoid the blood sugar increasing of diabetes type 2. The medicine is recommended as a combined therapie with Metformin or a Sulfanyl urea or both. The highest medicinal value of plasma followed after about two hours after the subcutaneous injection. Because of animal experiments, one can expect that the bio acceptance, namely the probability how the medicine works with human beings, is about 65 to 75 %. Clinical tests proved that the medicine which was injected two times a day reduces the blood sugar value if Metformin or Sulfanyl urea do not act any more. The most actual, but rare side effects are: feeling of sickness; vomiting; diarrhoea; affectation; vertigo; headache; indigestions. Interactions are indicated by: Digoxin; Lovastatin; Lisinopril and Acetaminophen. To begin with the medicine, it is recommended to take 5 ?g of it twice a day, in the morning and in the evening.
In what way the medicine is authorized in Europe/ Germany or in what way studies are done is not known to the editorial office from Diabetesindex.de.
Translated by Kristin Henke
|
Experiences | Diabetes Information | Contact | Board
|
| Linked articles: |
Linked Categories: |
|
|
|
|
| Comments (0) |
|
in Version 00.08.49